1 - 25 of 42 results for author:"Noelle R.J." in Literature citations
Results Customize
› Repeat search in UniProtKB (2)
| The diaphragms of fenestrated endothelia: gatekeepers of vascular permeability and blood composition. Stan R.V., Tse D., Deharvengt S.J., Smits N.C., Xu Y., Luciano M.R., McGarry C.L., Buitendijk M., Nemani K.V., Elgueta R. et al. Dev. Cell 23:1203-1218(2012) · Mapped (2) |
| Tryptophan hydroxylase-1 regulates immune tolerance and inflammation. Nowak E.C., de Vries V.C., Wasiuk A., Ahonen C., Bennett K.A., Le Mercier I., Ha D.G., Noelle R.J. J. Exp. Med. 209:2127-2135(2012) · Mapped (8) |
| Adjuvant immunotherapy of experimental autoimmune encephalomyelitis: immature myeloid cells expressing CXCL10 and CXCL16 attract CXCR3+CXCR6+ and myelin-specific T cells to the draining lymph nodes rather than the central nervous system. O'Connor R.A., Li X., Blumerman S., Anderton S.M., Noelle R.J., Dalton D.K. J. Immunol. 188:2093-2101(2012) · Mapped (17) |
| Mast cells condition dendritic cells to mediate allograft tolerance. de Vries V.C., Pino-Lagos K., Nowak E.C., Bennett K.A., Oliva C., Noelle R.J. Immunity 35:550-561(2011) · Mapped (7) |
| VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses. Wang L., Rubinstein R., Lines J.L., Wasiuk A., Ahonen C., Guo Y., Lu L.F., Gondek D., Wang Y., Fava R.A. et al. J. Exp. Med. 208:577-592(2011) · Mapped (4) |
| Mast cell protease 6 is required for allograft tolerance. de Vries V.C., Elgueta R., Lee D.M., Noelle R.J. Transplant. Proc. 42:2759-2762(2010) · Mapped (3) |
| Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis. Lievens D., Zernecke A., Seijkens T., Soehnlein O., Beckers L., Munnix I.C., Wijnands E., Goossens P., van Kruchten R., Thevissen L. et al. Blood 116:4317-4327(2010) · Mapped (19) |
| Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile. Lutgens E., Lievens D., Beckers L., Wijnands E., Soehnlein O., Zernecke A., Seijkens T., Engel D., Cleutjens J., Keller A.M. et al. J. Exp. Med. 207:391-404(2010) · Mapped (23) |
| IL-9 as a mediator of Th17-driven inflammatory disease. Nowak E.C., Weaver C.T., Turner H., Begum-Haque S., Becher B., Schreiner B., Coyle A.J., Kasper L.H., Noelle R.J. J. Exp. Med. 206:1653-1660(2009) · Mapped (16) |
| Transplantation survival is maintained by granzyme B+ regulatory cells and adaptive regulatory T cells. Gondek D.C., Devries V., Nowak E.C., Lu L.F., Bennett K.A., Scott Z.A., Noelle R.J. J. Immunol. 181:4752-4760(2008) · Mapped (6) |
| Programmed death 1 ligand signaling regulates the generation of adaptive Foxp3+CD4+ regulatory T cells. Wang L., Pino-Lagos K., de Vries V.C., Guleria I., Sayegh M.H., Noelle R.J. Proc. Natl. Acad. Sci. U.S.A. 105:9331-9336(2008) · Mapped (4) |
| Dendritic cells require the NF-kappaB2 pathway for cross-presentation of soluble antigens. Lind E.F., Ahonen C.L., Wasiuk A., Kosaka Y., Becher B., Bennett K.A., Noelle R.J. J. Immunol. 181:354-363(2008) · Mapped (18) |
| Cutting edge: the dependence of plasma cells and independence of memory B cells on BAFF and APRIL. Benson M.J., Dillon S.R., Castigli E., Geha R.S., Xu S., Lam K.P., Noelle R.J. J. Immunol. 180:3655-3659(2008) · Mapped (9) |
| The CD40-TRAF6 axis is the key regulator of the CD40/CD40L system in neointima formation and arterial remodeling. Donners M.M., Beckers L., Lievens D., Munnix I., Heemskerk J., Janssen B.J., Wijnands E., Cleutjens J., Zernecke A., Weber C. et al. Blood 111:4596-4604(2008) · Mapped (3) |
| The in vivo function of a noncanonical TRAF2-binding domain in the C-terminus of CD40 in driving B-cell growth and differentiation. Lu L.F., Ahonen C.L., Lind E.F., Raman V.S., Cook W.J., Lin L.L., Noelle R.J. Blood 110:193-200(2007) · Mapped (6) |
| Imprinting the fate of antigen-reactive B cells through the affinity of the B cell receptor. O'Connor B.P., Vogel L.A., Zhang W., Loo W., Shnider D., Lind E.F., Ratliff M., Noelle R.J., Erickson L.D. J. Immunol. 177:7723-7732(2006) · Mapped (1) |
| Mast cells are essential intermediaries in regulatory T-cell tolerance. Lu L.F., Lind E.F., Gondek D.C., Bennett K.A., Gleeson M.W., Pino-Lagos K., Scott Z.A., Coyle A.J., Reed J.L., Van Snick J. et al. Nature 442:997-1002(2006) · Mapped (4) |
| Characterization of (4-hydroxy-3-nitrophenyl)acetyl (NP)-specific germinal center B cells and antigen-binding B220- cells after primary NP challenge in mice. Wolniak K.L., Noelle R.J., Waldschmidt T.J. J. Immunol. 177:2072-2079(2006) · Mapped (4) |
| NF kappa B-inducing kinase deficiency results in the development of a subset of regulatory T cells, which shows a hyperproliferative activity upon glucocorticoid-induced TNF receptor family-related gene stimulation. Lu L.F., Gondek D.C., Scott Z.A., Noelle R.J. J. Immunol. 175:1651-1657(2005) · Mapped (3) |
| A critical role for the programmed death ligand 1 in fetomaternal tolerance. Guleria I., Khosroshahi A., Ansari M.J., Habicht A., Azuma M., Yagita H., Noelle R.J., Coyle A., Mellor A.L., Khoury S.J. et al. J. Exp. Med. 202:231-237(2005) · Mapped (2) |
| Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. Gondek D.C., Lu L.F., Quezada S.A., Sakaguchi S., Noelle R.J. J. Immunol. 174:1783-1786(2005) · Mapped (6) |
| BCMA is essential for the survival of long-lived bone marrow plasma cells. O'Connor B.P., Raman V.S., Erickson L.D., Cook W.J., Weaver L.K., Ahonen C., Lin L.L., Mantchev G.T., Bram R.J., Noelle R.J. J. Exp. Med. 199:91-98(2004) · Mapped (1) |
| A genetic lesion that arrests plasma cell homing to the bone marrow. Erickson L.D., Lin L.L., Duan B., Morel L., Noelle R.J. Proc. Natl. Acad. Sci. U.S.A. 100:12905-12910(2003) · Mapped (2) |
| CD40-mediated up-regulation of Toll-like receptor 4-MD2 complex on the surface of murine dendritic cells. Frleta D., Noelle R.J., Wade W.F. J. Leukoc. Biol. 74:1064-1073(2003) · Mapped (7) |
| CD40 signaling through a newly identified tumor necrosis factor receptor-associated factor 2 (TRAF2) binding site. Lu L.F., Cook W.J., Lin L.L., Noelle R.J. J. Biol. Chem. 278:45414-45418(2003) · Mapped (6) |